Milestone Pharmaceuticals | 3:首次持股声明-董事 PAPA JOSEPH C
Milestone Pharmaceuticals | 4:持股变动声明-董事 PAPA JOSEPH C
Milestone Pharmaceuticals | 8-K:重大事件
Milestone Pharmaceuticals | 4:持股变动声明-董事 Saik Andrew
Milestone Pharmaceuticals | 4:持股变动声明-董事 Giles Lisa M.
Milestone Pharmaceuticals | 4:持股变动声明-董事 Fischer Seth H. Z.
Milestone Pharmaceuticals | 4:持股变动声明-董事 TOMSICEK MICHAEL JOHN
Milestone Pharmaceuticals | 4:持股变动声明-董事 Wills Robert James
Milestone Pharmaceuticals | 8-K:Milestone Pharmicals公布2024年第二季度财务业绩并提供监管和公司最新情况
Milestone Pharmaceuticals | 10-Q:2024财年二季报
Milestone Pharmaceuticals | 4:持股变动声明-董事 Saik Andrew
Milestone Pharmaceuticals | 3:首次持股声明-董事 Saik Andrew
Milestone Pharmaceuticals | 3:首次持股声明-董事 Duty Stuart
Milestone Pharmaceuticals | 4:持股变动声明-董事 Duty Stuart
Milestone Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-Alta Fundamental Advisers LLC(4.99%),Gilbert Li(4.99%)等
Milestone Pharmaceuticals | ARS:年度报告
Milestone Pharmaceuticals | DEF 14A:股东委托书决议
Milestone Pharmaceuticals | DEFA14A:其他
Milestone Pharmaceuticals | DEFA14A:其他
Milestone Pharmaceuticals | 8-K:重大事件
暂无数据
暂无数据